Current Value of Holding

$948 Million

Shares

11.1 Million

% of Portfolio

2.84%

Average Buy Price

$93.9

Avg closing price
Price range

20 Sands Capital Dexcom Trades

Sands Capital's position in Dexcom is currently worth $948 Million. That's 2.84% of their equity portfolio (15th largest holding). The investor owns 2.96% of the outstanding Dexcom stock. The first Dexcom trade was made in Q1 2020. Since then Sands Capital bought shares ten more times and sold shares on nine occasions. The investor's estimated purchase price is $1.04 Billion, resulting in a loss of 9.1%.

Avg closing price
Price range
Increased shares by 7.7% (+790 Thousand shares) Q4 2024
Avg closing price $74.39
Price range $65.68 - $81.01
Sold 2.7% shares (-287 Thousand shares) Q3 2024
Avg closing price $82.36
Price range $64.00 - $116.06
Sold 2.7% shares (-290 Thousand shares) Q2 2024
Avg closing price $126.43
Price range $110.31 - $140.45
Sold 27.6% shares (-4.16 Million shares) Q1 2024
Avg closing price $125.70
Price range $114.22 - $140.10
Increased shares by 10.2% (+1.4 Million shares) Q4 2023
Avg closing price $102.16
Price range $75.49 - $124.16
Increased shares by 4.3% (+558 Thousand shares) Q3 2023
Avg closing price $112.73
Price range $86.06 - $137.93
Sold 4.6% shares (-636 Thousand shares) Q2 2023
Avg closing price $120.95
Price range $112.47 - $130.98
Sold 11.4% shares (-1.78 Million shares) Q1 2023
Avg closing price $111.94
Price range $104.00 - $122.92
Sold 7.1% shares (-1.18 Million shares) Q4 2022
Avg closing price $109.79
Price range $84.98 - $122.67
Sold 6.8% shares (-1.21 Million shares) Q3 2022
Avg closing price $84.70
Price range $76.35 - $94.18
Increased shares by 6.8% (+1.15 Million shares) Q2 2022
Avg closing price $91.26
Price range $67.99 - $132.89
Increased shares by 33.9% (+4.24 Million shares) Q1 2022
Avg closing price $109.39
Price range $94.08 - $130.20
Sold 5.9% shares (-783 Thousand shares) Q4 2021
Avg closing price $143.69
Price range $129.87 - $162.82
Increased shares by 9.5% (+1.15 Million shares) Q3 2021
Avg closing price $126.11
Price range $106.71 - $143.18
Increased shares by 3.4% (+403 Thousand shares) Q2 2021
Avg closing price $96.03
Price range $80.99 - $107.93
Sold 35.9% shares (-6.58 Million shares) Q1 2021
Avg closing price $93.87
Price range $84.79 - $104.74
Increased shares by 96.5% (+9 Million shares) Q4 2020
Avg closing price $89.29
Price range $78.00 - $104.50
Increased shares by 26.7% (+1.96 Million shares) Q3 2020
Avg closing price $104.48
Price range $95.51 - $112.95
Increased shares by 269.9% (+5.37 Million shares) Q2 2020
Avg closing price $89.45
Price range $62.68 - $105.34
New holding (+1.99 Million shares) Q1 2020
Avg closing price $62.22
Price range $47.79 - $75.63

News about Dexcom Inc and Sands Capital

Embed chart

Easily embed the chart on your blog or website – it will always update automatically!